Table: Ono Pharm -Q1 group results (IFRS)

ONO PHARMACEUTICAL

31/07/2024 04:00

Jul 31 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              117.68              120.02           450.00    
                   (-1.9 pct)          (+12.5 pct)      (-10.5 pct) 
  Operating           30.69               41.35           122.00    
                   (-25.8 pct)         (+8.3 pct)       (-23.7 pct) 
  Pretax              33.31               42.38           123.00    
                   (-21.4 pct)         (+8.5 pct)       (-24.9 pct) 
  Net                 24.79               31.82            91.00    
                   (-22.1 pct)         (+7.9 pct)       (-28.9 pct) 
  EPS Basic         52.79 yen           65.16 yen       193.76 yen  
  EPS Diluted       52.75 yen           65.15 yen                   
  Ann Div                               80.00 yen        80.00 yen  
  -Q2 Div                               40.00 yen        40.00 yen  
  -Q4 Div                               40.00 yen        40.00 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T